Weisenburger,
Wilson,
Staudt,
Ciszak,
Iqbal,
Sanger,
Masuda,
Delabie,
Fu,
Rosenwald,
Mitomi,
Campo,
Smith,
Ackermann,
Greiner,
Jaffe,
Chan,
Chiorazzi,
Rose,
Hartmann,
Strohmeyer,
Gascoyne,
van Diest,
Kuliczkowski,
Gesk,
Rimsza,
Okayasu,
Müller-Hermelink,
Teodorowska,
Takano,
Siebert,
Frydecka,
Braziel,
Dave,
Wolowiec,
Steinhoff,
Wright,
Kosmaczewska,
Ott,
Bocko,
De Jong,
Kato,
Schmidt,
Dave,
- Molecular characterization of 12p abnormalities in hematologic malignancies: deletion of KIP1, rearrangement of TEL, and amplification of CCND2. Höglund, M., Johansson, B., Pedersen-Bjergaard, J., Marynen, P., Mitelman, F. Blood (1996)
- Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations. Agnelli, L., Bicciato, S., Mattioli, M., Fabris, S., Intini, D., Verdelli, D., Baldini, L., Morabito, F., Callea, V., Lombardi, L., Neri, A. J. Clin. Oncol. (2005)
- Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas. Büschges, R., Weber, R.G., Actor, B., Lichter, P., Collins, V.P., Reifenberger, G. Brain Pathol. (1999)
- Study on the role of G1 cyclins in Epstein-Barr virus-associated human lymphomas maintained in severe combined immune deficiency (SCID) mice. Murai, Y., Dobashi, Y., Okada, E., Ishizawa, S., Shiota, M., Mori, S., Takano, Y. Int. J. Cancer (2001)
- Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias. Clappier, E., Cuccuini, W., Cayuela, J.M., Vecchione, D., Baruchel, A., Dombret, H., Sigaux, F., Soulier, J. Leukemia (2006)
- Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Ewen, M.E., Sluss, H.K., Sherr, C.J., Matsushime, H., Kato, J., Livingston, D.M. Cell (1993)
- Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Sicinski, P., Donaher, J.L., Geng, Y., Parker, S.B., Gardner, H., Park, M.Y., Robker, R.L., Richards, J.S., McGinnis, L.K., Biggers, J.D., Eppig, J.J., Bronson, R.T., Elledge, S.J., Weinberg, R.A. Nature (1996)
- Mitoxantrone mediates demethylation and reexpression of cyclin d2, estrogen receptor and 14.3.3sigma in breast cancer cells. Parker, B.S., Cutts, S.M., Nudelman, A., Rephaeli, A., Phillips, D.R., Sukumar, S. Cancer Biol. Ther. (2003)
- Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human. Morito, N., Yoh, K., Fujioka, Y., Nakano, T., Shimohata, H., Hashimoto, Y., Yamada, A., Maeda, A., Matsuno, F., Hata, H., Suzuki, A., Imagawa, S., Mitsuya, H., Esumi, H., Koyama, A., Yamamoto, M., Mori, N., Takahashi, S. Cancer Res. (2006)
- Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes. Virolle, T., Krones-Herzig, A., Baron, V., De Gregorio, G., Adamson, E.D., Mercola, D. J. Biol. Chem. (2003)
- Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. Matsubayashi, H., Sato, N., Fukushima, N., Yeo, C.J., Walter, K.M., Brune, K., Sahin, F., Hruban, R.H., Goggins, M. Clin. Cancer Res. (2003)
- The mitogenic signaling pathway for fibroblast growth factor-2 involves the tyrosine phosphorylation of cyclin D2 in MCF-7 human breast cancer cells. Vercoutter-Edouart, A., Lemoine, J., Smart, C.E., Nurcombe, V., Boilly, B., Peyrat, J., Hondermarck, H. FEBS Lett. (2000)
- Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Fu, K., Weisenburger, D.D., Greiner, T.C., Dave, S., Wright, G., Rosenwald, A., Chiorazzi, M., Iqbal, J., Gesk, S., Siebert, R., De Jong, D., Jaffe, E.S., Wilson, W.H., Delabie, J., Ott, G., Dave, B.J., Sanger, W.G., Smith, L.M., Rimsza, L., Braziel, R.M., Müller-Hermelink, H.K., Campo, E., Gascoyne, R.D., Staudt, L.M., Chan, W.C. Blood (2005)
- Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Xiong, Y., Menninger, J., Beach, D., Ward, D.C. Genomics (1992)
- DNA hypermethylation in breast cancer and its association with clinicopathological features. Li, S., Rong, M., Iacopetta, B. Cancer Lett. (2006)
- Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes. Li, G., Domenico, J., Lucas, J.J., Gelfand, E.W. J. Immunol. (2004)
- Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Houldsworth, J., Reuter, V., Bosl, G.J., Chaganti, R.S. Cell Growth Differ. (1997)
- Transforming growth factor B1 stimulated DNA synthesis in the granulosa cells of preantral follicles: negative interaction with epidermal growth factor. Yang, P., Roy, S.K. Biol. Reprod. (2006)
- Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma. Uchimaru, K., Taniguchi, T., Yoshikawa, M., Asano, S., Arnold, A., Fujita, T., Motokura, T. Blood (1997)
- Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells. Sweeney, K.J., Sarcevic, B., Sutherland, R.L., Musgrove, E.A. Oncogene (1997)
- Overexpression of cyclin D2 in chronic B-cell malignancies. Delmer, A., Ajchenbaum-Cymbalista, F., Tang, R., Ramond, S., Faussat, A.M., Marie, J.P., Zittoun, R. Blood (1995)
- Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells. Friedrichsen, B.N., Richter, H.E., Hansen, J.A., Rhodes, C.J., Nielsen, J.H., Billestrup, N., Møldrup, A. Mol. Endocrinol. (2003)
- Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Mukhopadhyay, A., Banerjee, S., Stafford, L.J., Xia, C., Liu, M., Aggarwal, B.B. Oncogene (2002)
- Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity. Tiedemann, R.E., Mao, X., Shi, C.X., Zhu, Y.X., Palmer, S.E., Sebag, M., Marler, R., Chesi, M., Fonseca, R., Bergsagel, P.L., Schimmer, A.D., Stewart, A.K. J. Clin. Invest. (2008)
- Follicle stimulating hormone-induced DNA synthesis in the granulosa cells of hamster preantral follicles involves activation of cyclin-dependent kinase-4 rather than cyclin d2 synthesis. Yang, P., Roy, S.K. Biol. Reprod. (2004)
- Regulation of cyclin D2 and the cyclin D2 promoter by protein kinase A and CREB in lymphocytes. White, P.C., Shore, A.M., Clement, M., McLaren, J., Soeiro, I., Lam, E.W., Brennan, P. Oncogene (2006)
- Glycogen synthase kinase-3beta and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin/proteasome-dependent degradation in hematopoietic cells. Kida, A., Kakihana, K., Kotani, S., Kurosu, T., Miura, O. Oncogene (2007)
- Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia. Wolowiec, D., Ciszak, L., Kosmaczewska, A., Bocko, D., Teodorowska, R., Frydecka, I., Kuliczkowski, K. Haematologica (2001)
- Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2. Chuang, S.S., Huang, W.T., Hsieh, P.P., Tseng, H.H., Campo, E., Colomer, D., Ye, H., Lu, C.L., Chang, H.M., Cho, C.Y., Huang, S.H., Lu, Y.C., Wu, J.D. Pathol. Int. (2006)
- Frequent deregulation of p16 and the p16/G1 cell cycle-regulatory pathway in neuroblastoma. Diccianni, M.B., Omura-Minamisawa, M., Batova, A., Le, T., Bridgeman, L., Yu, A.L. Int. J. Cancer (1999)
- FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. Fernández de Mattos, S., Essafi, A., Soeiro, I., Pietersen, A.M., Birkenkamp, K.U., Edwards, C.S., Martino, A., Nelson, B.H., Francis, J.M., Jones, M.C., Brosens, J.J., Coffer, P.J., Lam, E.W. Mol. Cell. Biol. (2004)
- Aberrant expression of G1-phase cell cycle regulators in flat and exophytic adenomas of the human colon. Bartkova, J., Thullberg, M., Slezak, P., Jaramillo, E., Rubio, C., Thomassen, L.H., Bartek, J. Gastroenterology (2001)
- Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors. Schmidt, B.A., Rose, A., Steinhoff, C., Strohmeyer, T., Hartmann, M., Ackermann, R. Cancer Res. (2001)
- Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Takano, Y., Kato, Y., van Diest, P.J., Masuda, M., Mitomi, H., Okayasu, I. Am. J. Pathol. (2000)
- Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation. Padar, A., Sathyanarayana, U.G., Suzuki, M., Maruyama, R., Hsieh, J.T., Frenkel, E.P., Minna, J.D., Gazdar, A.F. Clin. Cancer Res. (2003)
- High-level DNA amplifications are common genetic aberrations in B-cell neoplasms. Werner, C.A., Döhner, H., Joos, S., Trümper, L.H., Baudis, M., Barth, T.F., Ott, G., Möller, P., Lichter, P., Bentz, M. Am. J. Pathol. (1997)
- Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Lukas, J., Bartkova, J., Welcker, M., Petersen, O.W., Peters, G., Strauss, M., Bartek, J. Oncogene (1995)
- Cyclin D2 interacts with cdk-5 and modulates cellular cdk-5/p35 activity. Guidato, S., McLoughlin, D.M., Grierson, A.J., Miller, C.C. J. Neurochem. (1998)